Plain-English translation of NCT07459309 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a multimodal thermal ablation system — a treatment that uses heat to destroy liver cancer tumors. The study will look at whether this treatment is safe and effective, and how it affects the body's immune system. Researchers want to understand if this approach works well for patients with primary liver cancer or cancer that has spread to the liver.
Many patients with liver cancer cannot have surgery or choose not to have it. This treatment offers another option by using heat to target and destroy tumors without removing large amounts of liver tissue, and researchers want to learn how well it works and whether it helps the body fight cancer.
You likely qualify if…
You likely don't qualify if…
You would receive the multimodal thermal ablation treatment, which uses heat to destroy your liver tumor. The study will monitor your safety and measure how well the treatment works, including checking your body's immune response. You'll need to be able to visit the hospital for the procedure and follow-up visits to ensure the treatment is working and that you're doing well.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
China
Sponsor
Fudan University
Enrollment target
~20 participants
Started
April 2026
Primary completion
December 2026
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
wentao li
Fudan University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.